Literature DB >> 1156113

Cerebrospinal fluid amine metabolites in acute schizophrenia.

R M Post, E Fink, W T Carpenter, F K Goodwin.   

Abstract

The metabolites of serotonin, dopamine, and norepinephrine, 5-hydroxyindoleacetic acid (5HIAA), homovanillic acid (HVA), and 3-methoxy-4-hydroxy-phenylethylene glycol (MHPG), respectively, were studied in cerebrospinal fluid of patients with acute schizophrenia. Base line levels of these metabolites were not significantly different from those in normal, neurological, and affectively ill controls. Accumulations of 5HIAA and HVA following probenecid administration, which provide a measure of serotonin and dopamine turnover, were also not significantly different in patients with acute schizophrenia and affective illness. After patients had recovered from their acute schizophrenic illness, HVA accumulations were significantly reduced. We discuss results in relation to amine hypotheses of schizophrenia and the suggestion that altered dopamine metabolism may reflect a biological change predisposing to acute schizophrenia.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1156113     DOI: 10.1001/archpsyc.1975.01760260127011

Source DB:  PubMed          Journal:  Arch Gen Psychiatry        ISSN: 0003-990X


  20 in total

1.  The fallacy of the medical model and the dangers of psychotropic drugs as a mode of treatment for mental disorders.

Authors:  V D Sanua
Journal:  J Prim Prev       Date:  1996-09

2.  Endogenous ligands of a putative LSD-serotonin receptor in the cerebrospinal fluid: higher level of LSD-displacing factors (LDF) in unmedicated psychotic patients.

Authors:  E Mehl; E Rüther; J Redemann
Journal:  Psychopharmacology (Berl)       Date:  1977-08-31       Impact factor: 4.530

Review 3.  The biology of schizophrenia.

Authors:  T J Crow
Journal:  Experientia       Date:  1982-11-15

Review 4.  Molecular pathology of schizophrenia: more than one disease process?

Authors:  T J Crow
Journal:  Br Med J       Date:  1980-01-12

Review 5.  Dopamine system dysregulation by the ventral subiculum as the common pathophysiological basis for schizophrenia psychosis, psychostimulant abuse, and stress.

Authors:  Anthony A Grace
Journal:  Neurotox Res       Date:  2010-02-09       Impact factor: 3.911

Review 6.  Dopamine system dysregulation by the hippocampus: implications for the pathophysiology and treatment of schizophrenia.

Authors:  Anthony A Grace
Journal:  Neuropharmacology       Date:  2011-05-23       Impact factor: 5.250

7.  Cyclic GMP in the CSF of patients with schizophrenia before and after neuroleptic treatment.

Authors:  R P Ebstein; J Biederman; R Rimon; J Zohar; R H Belmaker
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

8.  Determination of 3-methoxy-4-hydroxyphenylglycol conjugates in urine. Application to the study of central noradrenaline metabolism in unmedicated chronic schizophrenic patients.

Authors:  M H Joseph; H F Baker; E C Johnstone; T J Crow
Journal:  Psychopharmacology (Berl)       Date:  1976-12-21       Impact factor: 4.530

9.  Partial improvement in negative schizophrenic symptoms after amphetamine.

Authors:  B Angrist; E Peselow; M Rubinstein; J Corwin; J Rotrosen
Journal:  Psychopharmacology (Berl)       Date:  1982       Impact factor: 4.530

Review 10.  The role of serotonin in schizophrenia: an overview of the nomenclature, distribution and alterations of serotonin receptors in the central nervous system.

Authors:  D C Ohuoha; T M Hyde; J E Kleinman
Journal:  Psychopharmacology (Berl)       Date:  1993       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.